Asset Details
Do you wish to reserve the book?
In Parkinson's patient-derived dopamine neurons, the triplication of alpha-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
In Parkinson's patient-derived dopamine neurons, the triplication of alpha-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition
Do you wish to request the book?
In Parkinson's patient-derived dopamine neurons, the triplication of alpha-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
In Parkinson's patient-derived dopamine neurons, the triplication of alpha-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition
2021
Overview
Pathophysiological changes in dopamine neurons precede their demise and contribute to the early phases of Parkinson's disease (PD). Intracellular pathological inclusions of the protein [alpha]-synuclein within dopaminergic neurons are a cardinal feature of PD, but the mechanisms by which [alpha]-synuclein contributes to dopaminergic neuron vulnerability remain unknown. The inaccessibility to diseased tissue has been a limitation in studying progression of pathophysiology prior to degeneration of dopamine neurons. To address these issues, we differentiated induced pluripotent stem cells (iPSCs) from a PD patient carrying the [alpha]-synuclein triplication mutation (AST) and an unaffected first-degree relative (NAS) into dopaminergic neurons. In human-like dopamine neurons [alpha]-synuclein overexpression reduced the functional availability of D2 receptors, resulting in a stark dysregulation in firing activity, dopamine release, and neuronal morphology. We back-translated these findings into primary mouse neurons overexpressing [alpha]-synuclein and found a similar phenotype, supporting the causal role for [alpha]-synuclein. Importantly, application of D2 receptor agonist, quinpirole, restored the altered firing activity of AST-derived dopaminergic neurons to normal levels. These results provide novel insights into the pre-degenerative pathophysiological neuro-phenotype induced by [alpha]-synuclein overexpression and introduce a potential mechanism for the long-established clinical efficacy of D2 receptor agonists in the treatment of PD. Keywords: [alpha]-synuclein, iPSCs, Dopamine neurons, D2 receptor, Parkinson's disease
Publisher
BioMed Central Ltd
Subject
